C. Anderson, R. Townley, M. Freeman, and P. Johansen, Unusual causes of steatorrhoea in infancy and childhood, pp.617-622, 1961.

C. Polonovski, J. Navarro, J. Fontaine, F. De-gouyon, and J. Saudubray, Cathelineau L: Maladie d'Anderson, Ann Pediatr, vol.17, pp.342-354, 1970.

J. Costil and . Maladie-d-'anderson, Journées Parisiennes de Pédiatrie Flammarion Editeurs Paris, pp.229-239

B. Scott, J. Miller, and M. Losowski, Hypobetalipoproteinaemia--a variant of the Bassen-Kornzweig syndrome., Gut, vol.20, issue.2, pp.163-168, 1979.
DOI : 10.1136/gut.20.2.163

S. Gauthier and A. Sniderman, Action tremor as a manifestation of chylomicron retention disease, Annals of Neurology, vol.64, issue.5, p.591, 1983.
DOI : 10.1002/ana.410140517

M. Bouma, I. Beucler, L. Aggerbeck, R. Infante, and J. Schmitz, Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease., Journal of Clinical Investigation, vol.78, issue.2, pp.398-410, 1986.
DOI : 10.1172/JCI112590

I. Polenco, M. Mellado, R. Lama, J. Larrauri, A. Zapata et al., Anderson's disease, An Esp Pediatr, vol.24, pp.185-188, 1986.

C. Roy, E. Levy, P. Green, A. Sniderman, J. Letartre et al., Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B, Gastroenterology, vol.92, issue.2, pp.390-399, 1987.
DOI : 10.1016/0016-5085(87)90133-8

E. Levy, Y. Marcel, R. Deckelbaum, R. Milne, G. Lepage et al., Intestinal apoB synthesis, lipids, and lipoproteins in chylomicron retention disease, J Lipid Res, vol.28, pp.1263-1274, 1987.

F. Lacaille, M. Bratos, M. Bouma, J. Jos, J. Schmitz et al., Anderson's disease. Clinical and morphologic study of 7 cases, Arch Fr Pediatr, vol.46, pp.491-498, 1989.

D. Strich, R. Goldstein, A. Phillips, R. Shemer, Y. Goldberg et al., Anderson??s Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.16, issue.3, pp.257-264, 1993.
DOI : 10.1097/00005176-199304000-00006

A. Nemeth, U. Myrdal, B. Veress, M. Rudling, L. Berglund et al., Studies on lipoprotein metabolism in a family with jejunal chylomicron retention, European Journal of Clinical Investigation, vol.28, issue.4, pp.271-280, 1995.
DOI : 10.1007/BF02535122

M. Benavent, M. Casanova, A. Perez, C. Konickx, and J. Calvete, Anderson's disease (steatorrhea due to the retention of chylomicrons) : diagnostic criteria, An Esp Pediatr, vol.47, pp.195-198, 1997.

A. Dannoura, N. Berriot-varoqueaux, P. Amati, V. Abadie, N. Verthier et al., Anderson's Disease : Exclusion of Apolipoprotein and Intracellular Lipid Transport Genes, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.10, pp.2494-2508, 1999.
DOI : 10.1161/01.ATV.19.10.2494

R. Biselli, R. Boldrini, D. Altilia, M. Bosman, and C. , Celiac disease or chylomicron retention disease? Pathologica, p.130, 2000.

R. Boldrini, R. Biselli, and C. Bosman, Chylomicron retention disease?the role of ultrastructural examination in differential diagnosis, Pathol Res Pract, vol.197, pp.753-757, 2001.

B. Jones, E. Jones, S. Bonney, H. Patel, A. Mensenkamp et al., Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders, Nature Genetics, vol.34, issue.1, pp.29-31, 2003.
DOI : 10.1038/ng1145

M. Charcosset, A. Sassolas, N. Peretti, C. Roy, C. Deslandres et al., Anderson or chylomicron retention disease: Molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein, Molecular Genetics and Metabolism, vol.93, issue.1, pp.74-84, 2008.
DOI : 10.1016/j.ymgme.2007.08.120

G. Annesi, U. Aguglia, P. Tarantino, F. Annesi, D. Marco et al., SIL1 and SARA2 mutations in Marinesco-Sj??gren and chylomicron retention diseases, Clinical Genetics, vol.34, issue.3, pp.288-289, 2007.
DOI : 10.1111/j.1399-0004.2007.00759.x

M. Silvain, D. Bligny, T. Aparicio, P. Laforet, A. Grodet et al., Anderson???s disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities, Clinical Genetics, vol.16, issue.3, pp.546-552, 2008.
DOI : 10.1111/j.1399-0004.2008.01069.x

S. Treepongkaruna, N. Chongviriyaphan, U. Suthutvoravut, D. Charoenpipop, L. Choubtum et al., Novel Missense Mutations of SAR1B Gene in an Infant With Chylomicron Retention Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.48, issue.3, pp.370-373, 2009.
DOI : 10.1097/MPG.0b013e318183188f

A. Cefalu, P. Calvo, D. Noto, M. Baldi, V. Valenti et al., Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene, Metabolism, vol.59, issue.4, pp.463-467, 2010.
DOI : 10.1016/j.metabol.2009.07.042

N. Peretti, C. Roy, A. Sassolas, C. Deslandres, E. Drouin et al., Chylomicron retention disease: A long term study of two cohorts, Molecular Genetics and Metabolism, vol.97, issue.2, pp.136-142, 2009.
DOI : 10.1016/j.ymgme.2009.02.003

G. Bernard, M. Panisset, A. Sadikot, and S. Chouinard, Chylomicron retention disease: Dystonia as a new clinical feature, Movement Disorders, vol.25, issue.11, pp.1755-1756, 2010.
DOI : 10.1002/mds.23165

N. Peretti, A. Sassolas, C. Roy, C. Deslandres, M. Charcosset et al., Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers, Orphanet Journal of Rare Diseases, vol.5, issue.1, p.24, 2010.
DOI : 10.1186/1750-1172-5-24

URL : https://hal.archives-ouvertes.fr/inserm-00654377

C. Gurkan, S. Stagg, P. Lapointe, and W. Balch, The COPII cage: unifying principles of vesicle coat assembly, Nature Reviews Molecular Cell Biology, vol.174, issue.10, pp.727-738, 2006.
DOI : 10.1038/nrm2025

J. Fromme, L. Orci, and R. Schekman, Coordination of COPII vesicle trafficking by Sec23, Trends in Cell Biology, vol.18, issue.7, pp.330-336, 2008.
DOI : 10.1016/j.tcb.2008.04.006

S. Stagg, P. Lapointe, A. Razvi, C. Gurkan, C. Potter et al., Structural Basis for Cargo Regulation of COPII Coat Assembly, Cell, vol.134, issue.3, pp.474-484, 2008.
DOI : 10.1016/j.cell.2008.06.024

H. Hughes and D. Stephens, Assembly, organization, and function of the COPII coat, Histochemistry and Cell Biology, vol.119, issue.2, pp.129-151, 2008.
DOI : 10.1007/s00418-007-0363-x

S. Siddiqi, F. Gorelick, J. Mahan, and C. Mansbach, COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle, Journal of Cell Science, vol.116, issue.2, pp.415-427, 2003.
DOI : 10.1242/jcs.00215

I. Neeli, S. Siddiqi, S. Siddiqi, J. Mahan, W. Lagakos et al., Liver Fatty Acid-binding Protein Initiates Budding of Pre-chylomicron Transport Vesicles from Intestinal Endoplasmic Reticulum, Journal of Biological Chemistry, vol.282, issue.25, pp.17974-17984, 2007.
DOI : 10.1074/jbc.M610765200

S. Siddiqi, U. Saleem, N. Abumrad, N. Davidson, J. Storch et al., A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER, The Journal of Lipid Research, vol.51, issue.7, pp.1918-1928, 2010.
DOI : 10.1194/jlr.M005611

S. Siddiqi, S. Siddiqi, and C. Mansbach, Sec24C is required for docking the prechylomicron transport vesicle with the Golgi, The Journal of Lipid Research, vol.51, issue.5, pp.1093-1100, 2010.
DOI : 10.1194/jlr.M002758

C. Mansbach and S. Siddiqi, The Biogenesis of Chylomicrons, Annual Review of Physiology, vol.72, issue.1, pp.315-333, 2010.
DOI : 10.1146/annurev-physiol-021909-135801

M. Abifadel, M. Varret, J. Rabes, D. Allard, K. Ouguerram et al., Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, pp.154-156, 2003.
DOI : 10.1038/ng1161

M. Abifadel, J. Rabes, M. Devillers, A. Munnich, D. Erlich et al., ) gene in cholesterol metabolism and disease, Human Mutation, vol.79, issue.4, pp.520-529, 2009.
DOI : 10.1002/humu.20882

J. Horton, J. Cohen, and H. Hobbs, PCSK9: a convertase that coordinates LDL catabolism, The Journal of Lipid Research, vol.50, issue.Supplement, pp.172-179, 2009.
DOI : 10.1194/jlr.R800091-JLR200

G. Lambert, F. Charlton, K. Rye, and D. Piper, Molecular basis of PCSK9 function, Atherosclerosis, vol.203, issue.1, pp.1-7, 2009.
DOI : 10.1016/j.atherosclerosis.2008.06.010

C. Allain, L. Poon, C. Chan, R. W. Fu, and P. , Enzymatic determination of total serum cholesterol, Clin Chem, vol.20, pp.470-475, 1974.

P. Fossati and L. Prencipe, Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide, Clin Chem, vol.28, pp.2077-2080, 1982.

M. Egloff, D. Leglise, L. Duvillard, J. Steinmetz, M. Boyer et al., Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay, Ann Biol Clin, vol.57, pp.561-572, 1999.

W. Friedewald, R. Levy, and D. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, vol.18, pp.499-502, 1972.

J. Albers, S. Marcovina, and H. Kennedy, International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials, Clin Chem, vol.38, pp.658-662, 1992.

S. Salmon, S. Goldstein, D. Pastier, L. Theron, M. Berthelier et al., Monoclonal antibodies to low density lipoprotein used for the study of low- and very-low-density lipoproteins, in ???ELISA??? and immunoprecipitation technics, Biochemical and Biophysical Research Communications, vol.125, issue.2, pp.704-711, 1984.
DOI : 10.1016/0006-291X(84)90596-5

R. Pease, R. Milne, W. Jessup, A. Law, P. Provost et al., Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B-100, J Biol Chem, vol.265, pp.553-568, 1990.

K. Livak and T. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, pp.402-408, 2001.

J. Patsch, G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp et al., Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.12, issue.11, pp.1336-1345, 1992.
DOI : 10.1161/01.ATV.12.11.1336

P. Yue, M. Averna, X. Lin, and G. Schonfeld, The c.43_44insCTG variation inPCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population, Human Mutation, vol.54, issue.5, pp.460-466, 2006.
DOI : 10.1002/humu.20316

A. Su, T. Wiltshire, S. Batalov, H. Lapp, K. Ching et al., A gene atlas of the mouse and human protein-encoding transcriptomes, Proceedings of the National Academy of Sciences, vol.101, issue.16, pp.6062-6067, 2004.
DOI : 10.1073/pnas.0400782101

C. Gurkan, H. Lapp, C. Alory, A. Su, J. Hogenesch et al., Large-Scale Profiling of Rab GTPase Trafficking Networks: The Membrome, Molecular Biology of the Cell, vol.16, issue.8, pp.3847-3864, 2005.
DOI : 10.1091/mbc.E05-01-0062

D. Jardim, A. Da-cunha, D. Ada, S. Santos, C. Saad et al., Expression of Sara2 Human Gene in Erythroid Progenitors, BMB Reports, vol.38, issue.3, pp.328-333, 2005.
DOI : 10.5483/BMBRep.2005.38.3.328

K. Schwarz, A. Iolascon, F. Verissimo, N. Trede, W. Horsley et al., Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II, Nature Genetics, vol.426, issue.8, pp.936-940, 2009.
DOI : 10.1038/35055042

R. Cooper, J. Durocher, and M. Leslie, Decreased Fluidity of Red Cell Membrane Lipids in Abetalipoproteinemia, Journal of Clinical Investigation, vol.60, issue.1, pp.115-121, 1977.
DOI : 10.1172/JCI108747

J. Frézal, J. Rey, J. Polonovski, G. Levy, and M. Lamy, L'absence congénital de beta-lipoprotéines: étude de l'absorption des graisses après exsanguinotransfusion et mesure de la demi-vie des betalipoprotéines injectées, Rev Fr Clin Biol, vol.6, pp.677-683, 1961.

R. Cooper and C. Gulbrandsen, The relationship between serum lipoproteins and red cell membranes in abetalipoproteinemia and deficiency of lecithin cholesterol acyl transferase, J Lab Clin Med, vol.78, pp.323-335, 1971.

J. Schwartz, L. Rowland, H. Eder, P. Marks, E. Osterman et al., Bassen-Kornzweig Syndrome: Deficiency of Serum ??-Lipoprotein, Archives of Neurology, vol.8, issue.4, pp.438-454, 1963.
DOI : 10.1001/archneur.1963.00460040108010

J. Perrin, A. Georges, A. Morali, C. Vigneron, T. Lecompte et al., Acanthocytes and hypocholesterolemia, Ann Biol Clin Paris, vol.66, pp.569-572, 2008.

T. Taneja, J. Mankouri, R. Karnik, S. Kannan, A. Smith et al., Sar1-GTPase-dependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism, Human Molecular Genetics, vol.18, issue.13, pp.2400-2413, 2009.
DOI : 10.1093/hmg/ddp179

S. Rashid, D. Curtis, R. Garuti, N. Anderson, Y. Bashmakov et al., Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9, Proceedings of the National Academy of Sciences, vol.102, issue.15, pp.5374-5379, 2005.
DOI : 10.1073/pnas.0501652102

D. Zhang, T. Lagace, R. Garuti, Z. Zhao, M. Mcdonald et al., Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation, Journal of Biological Chemistry, vol.282, issue.25, pp.18602-18612, 2007.
DOI : 10.1074/jbc.M702027200

Z. Zhao, Y. Tuakli-wosornu, T. Lagace, L. Kinch, N. Grishin et al., Molecular Characterization of Loss-of-Function Mutations in PCSK9 and Identification of a Compound Heterozygote, The American Journal of Human Genetics, vol.79, issue.3, pp.514-523, 2006.
DOI : 10.1086/507488

A. Hooper, A. Marais, D. Tanyanyiwa, and J. Burnett, The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population, Atherosclerosis, vol.193, issue.2, pp.445-448, 2007.
DOI : 10.1016/j.atherosclerosis.2006.08.039

T. Leren and K. Berge, Identification of mutations in the apolipoprotein B-100 gene and in the PCSK9 gene as the cause of hypocholesterolemia, Clinica Chimica Acta, vol.397, issue.1-2, pp.92-95, 2008.
DOI : 10.1016/j.cca.2008.07.025

C. Russell and S. Stagg, New Insights into the Structural Mechanisms of the COPII Coat, Traffic, vol.136, issue.3, pp.303-310, 2010.
DOI : 10.1111/j.1600-0854.2009.01026.x

S. Siddiqi and C. Mansbach, PKC??-mediated phosphorylation controls budding of the pre-chylomicron transport vesicle, Journal of Cell Science, vol.121, issue.14, pp.2327-2338, 2008.
DOI : 10.1242/jcs.022780

E. Newberry, Y. Xie, S. Kennedy, J. Luo, and N. Davidson, Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice, Hepatology, vol.40, issue.5, pp.1191-1205, 2006.
DOI : 10.1002/hep.21369

E. Newberry, S. Kennedy, Y. Xie, J. Luo, and N. Davidson, Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice, Molecular and Cellular Biochemistry, vol.48, issue.1-2, pp.79-86, 2009.
DOI : 10.1007/s11010-008-0002-4

S. Siddiqi, J. Mahan, S. Siddiqi, F. Gorelick, and C. Mansbach, Vesicle-associated membrane protein 7 is expressed in intestinal ER, Journal of Cell Science, vol.119, issue.5, pp.943-950, 2006.
DOI : 10.1242/jcs.02803

S. Siddiqi, S. Siddiqi, J. Mahan, K. Peggs, F. Gorelick et al., The Identification of a Novel Endoplasmic Reticulum to Golgi SNARE Complex Used by the Prechylomicron Transport Vesicle, Journal of Biological Chemistry, vol.281, issue.30, pp.20974-20982, 2006.
DOI : 10.1074/jbc.M601401200

S. Boyadjiev, J. Fromme, J. Ben, S. Chong, C. Nauta et al., Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking, Nature Genetics, vol.307, issue.10, pp.1192-1197, 2006.
DOI : 10.1016/j.modgep.2005.03.002

J. Fromme, M. Ravazzola, S. Hamamoto, M. Balwi, W. Eyaid et al., The Genetic Basis of a Craniofacial Disease Provides Insight into COPII Coat Assembly, Developmental Cell, vol.13, issue.5, pp.623-634, 2007.
DOI : 10.1016/j.devcel.2007.10.005

J. Merte, D. Jensen, K. Wright, S. Sarsfield, Y. Wang et al., Sec24b selectively sorts Vangl2 to regulate planar cell polarity during neural tube closure, Nature Cell Biology, vol.13, issue.1, pp.41-46, 2010.
DOI : 10.1074/jbc.M411091200

J. Fromme and R. Schekman, COPII-coated vesicles: flexible enough for large cargo?, Current Opinion in Cell Biology, vol.17, issue.4, pp.345-352, 2005.
DOI : 10.1016/j.ceb.2005.06.004

S. Siddiqi, VLDL exits from the endoplasmic reticulum in a specialized vesicle, the VLDL transport vesicle, in rat primary hepatocytes, Biochemical Journal, vol.413, issue.2, pp.333-342, 2008.
DOI : 10.1042/BJ20071469

S. Siddiqi, A. Mani, and S. Siddiqi, -Golgi, Biochemical Journal, vol.265, issue.2, pp.391-401, 2010.
DOI : 10.1091/mbc.E02-09-0556

URL : https://hal.archives-ouvertes.fr/hal-01435327

V. Gusarova, J. Brodsky, and E. Fisher, Apolipoprotein B100 Exit from the Endoplasmic Reticulum (ER) Is COPII-dependent, and Its Lipidation to Very Low Density Lipoprotein Occurs Post-ER, Journal of Biological Chemistry, vol.278, issue.48, pp.48051-48058, 2003.
DOI : 10.1074/jbc.M306898200

I. Duluc, B. Jost, and J. Freund, Multiple levels of control of the stage- and region-specific expression of rat intestinal lactase, The Journal of Cell Biology, vol.123, issue.6, pp.1577-1586, 1993.
DOI : 10.1083/jcb.123.6.1577

L. Maiuri, M. Rossi, V. Raia, V. Garipoli, L. Hughes et al., Mosaic regulation of lactase in human adult-type hypolactasia, Gastroenterology, vol.107, issue.1, pp.54-60, 1994.
DOI : 10.1016/0016-5085(94)90060-4

M. Wong, J. Saam, T. Stappenbeck, C. Rexer, and J. Gordon, Genetic mosaic analysis based on Cre recombinase and navigated laser capture microdissection, Proceedings of the National Academy of Sciences, vol.97, issue.23, pp.12601-12606, 2000.
DOI : 10.1073/pnas.230237997

D. Rubin, D. Ong, and J. Gordon, Cellular differentiation in the emerging fetal rat small intestinal epithelium: mosaic patterns of gene expression., Proceedings of the National Academy of Sciences, vol.86, issue.4, pp.1278-1282, 1989.
DOI : 10.1073/pnas.86.4.1278

. Georges, Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease), Orphanet Journal of Rare Diseases, vol.6, issue.1, 2011.
DOI : 10.1186/1750-1172-6-1